Head-to-head comparison
GoodRx vs Vytora Health
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
GoodRx (NASDAQ: GDRX) is the largest US prescription savings platform.
$299/mo (brand-name) tirz · Verified July 2026
Marked down on: Requires a valid prescription — GoodRx is a discount card, not a prescriber; you still need a clinician to write the script
Desk Score
Compounded semaglutide at $179 a month or $149 on a 3-month plan, tirzepatide at $249 or $199, plus brand Mounjaro and Zepbound at $1,399 a month — all-inclusive, no membership fee.
$179/mo sema · $249/mo tirz · Verified August 2026
Marked down on: Injectable only — no oral route
Vytora Health takes this head-to-head with the higher Desk Score, 89/100 (B+) against 74/100 (C) for GoodRx. GoodRx still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
GoodRx
74/100
C
Vytora Health
89/100
B+
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | GoodRx | Vytora Health |
|---|---|---|
| Semaglutide | Not listed on GoodRx's site (checked July 2026) | $179/mo$179/mo month-to-month; $149/mo on a 3-month plan ($447 every 3 months); same price at every dose; compounded injectable |
| Tirzepatide | $299/mobrand-name$299/mo (brand Zepbound) | $249/mo$249/mo month-to-month; $199/mo on a 3-month plan ($599 every 3 months); same price at every dose; compounded injectable |
| Coverage | All 50 states | All 50 states and DC |
| Brand-name | Yes | Yes |
| Oral option | Injectable only | Injectable only |
| Best for | Self-pay brand-name Foundayo and Zepbound KwikPen at retail pharmacies. | Someone who wants a low compounded price without prepaying a year, and the option to move to brand tirzepatide on the same account. |
| Desk Score | 74/100C | 89/100B+ |
The verdict
Desk pick — Vytora HealthVytora Health takes this head-to-head with the higher Desk Score, 89/100 (B+) against 74/100 (C) for GoodRx. GoodRx still holds its ground where its strengths line up with yours.
Choose GoodRx if…
Self-pay brand-name Foundayo and Zepbound KwikPen at retail pharmacies.
$299/mo (brand-name) tirz · All 50 states
Choose Vytora Health if…
Someone who wants a low compounded price without prepaying a year, and the option to move to brand tirzepatide on the same account.
$179/mo sema · $249/mo tirz · All 50 states and DC
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: GoodRx · Vytora Health.
Also here
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- CoreAge Rx vs GoodRx
- CoreAge Rx vs Vytora Health
- Eden vs GoodRx
- Ondra Health vs Vytora Health
- GoodRx vs Pallas Health
- Sesame Care vs Vytora Health
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.